Last Updated On 7/28/2023 10:26:24 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
Company: Bayer |
Recipient: You |
|
Consulting or Advisory Role |
Company: Seattle Genetics |
Recipient: You |
Company: Bicara Therapeutics |
Recipient: You |
Company: Redesign Health |
Recipient: You |
Company: GlaxoSmithKline |
Recipient: You |
Company: Bayer |
Recipient: You |
Company: Pfizer |
Recipient: You |
Company: CytomX Therapeutics |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Pharmavite |
Recipient: Your Institution |
Company: Revolution Medicines |
Recipient: Your Institution |
Company: Evergrande Group |
Recipient: Your Institution |
Company: Janssen |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
No Relationships to Disclose |
|
|
(OPTIONAL) Open Payments Link |
No Relationships to Disclose |
|
|